AZN: AstraZeneca PLC Stocks News on November 14, 2025

Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market

AZN

Yahoo Finance

a day ago

Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market

AZN

MT Newswires

a day ago

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading

BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie

AZN

Investor's Business Daily

2 days ago

BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie

The FDA Has a New Drug Chief. What it Means for Biotech Stocks.

AZN

Barrons.com

2 days ago

The FDA Has a New Drug Chief. What it Means for Biotech Stocks.

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term

AZN

Zacks

2 days ago

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

AZN

Zacks

3 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Stock Market Today: Dow Up On Shutdown Deal; Cathie Wood Loads Up On This (Live Coverage)

AZN

Investor's Business Daily

4 days ago

Stock Market Today: Dow Up On Shutdown Deal; Cathie Wood Loads Up On This (Live Coverage)

AZN

MT Newswires

4 days ago

European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading

Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial

AZN

Business Wire

5 days ago

Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial

AstraZeneca (LSE:AZN): Is There Value Left After Recent Steady Gains?

AZN

Simply Wall St.

6 days ago

AstraZeneca (LSE:AZN): Is There Value Left After Recent Steady Gains?

AZN

MT Newswires

7 days ago

AstraZeneca Says Fasenra Delayed Disease Worsening in Late-Stage Trial for Hypereosinophilic Syndrome

AZN

Morningstar Research

7 days ago

Analyst Report: AstraZeneca PLC

Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease

AZN

Business Wire

7 days ago

Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease

Earnings live: Block stock drops after earnings miss, Airbnb pops, Opendoor pitches turnaround plan

AZN

Yahoo Finance

7 days ago

Earnings live: Block stock drops after earnings miss, Airbnb pops, Opendoor pitches turnaround plan

CEO Says AstraZeneca Can ‘Absorb’ Costs of Trump-Driven US Deals

AZN

The Daily Upside

7 days ago

CEO Says AstraZeneca Can ‘Absorb’ Costs of Trump-Driven US Deals

AZN

Zacks

7 days ago

Company News for Nov 7, 2025

3 UK Stocks Estimated To Be Up To 50% Below Intrinsic Value

AZN

Simply Wall St.

8 days ago

3 UK Stocks Estimated To Be Up To 50% Below Intrinsic Value

AZN

The Wall Street Journal

8 days ago

Health Care Roundup: Market Talk

Why AstraZeneca Stock Topped the Market on Thursday

AZN

Motley Fool

8 days ago

Why AstraZeneca Stock Topped the Market on Thursday

AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat

AZN

Investor's Business Daily

8 days ago

AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat

AZN

MT Newswires

8 days ago

Sector Update: Health Care Stocks Mixed Premarket Thursday

Is There Still Opportunity in AstraZeneca After Strong 28% Share Price Gain?

AZN

Simply Wall St.

8 days ago

Is There Still Opportunity in AstraZeneca After Strong 28% Share Price Gain?

AZN

MT Newswires

8 days ago

Sector Update: Health Care

AstraZeneca Shares Jump; Drugmaker Keeps Outlook As Cancer Drug Sales Soar

AZN

Investor's Business Daily

8 days ago

AstraZeneca Shares Jump; Drugmaker Keeps Outlook As Cancer Drug Sales Soar

Earnings live: Moderna stock pops amid cost-cutting efforts, Snap stock soars, Duolingo plunges

AZN

Yahoo Finance

8 days ago

Earnings live: Moderna stock pops amid cost-cutting efforts, Snap stock soars, Duolingo plunges

AstraZeneca CEO bullish on record revenue numbers and US growth

AZN

Yahoo Finance Video

8 days ago

AstraZeneca CEO bullish on record revenue numbers and US growth

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

AZN

GlobeNewswire

8 days ago

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

AstraZeneca's 9M and Q3 2025 Financial Results

AZN

Business Wire

8 days ago

AstraZeneca's 9M and Q3 2025 Financial Results

CNS Summit releases annual Digital Innovation Index

AZN

PR Newswire

9 days ago

CNS Summit releases annual Digital Innovation Index

Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost

AZN

Yahoo Finance

9 days ago

Earnings live: AMD, Supermicro, and Novo Nordisk stocks fall, Pinterest tanks while Lemonade gets a boost

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

AZN

Business Wire

9 days ago

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®

AZN

GlobeNewswire

10 days ago

HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®

Gastric Cancer Global and Regional Market Analysis 2025-2035: Focus on Treatment Type and End User with Profiles of Daiichi Sankyo, AstraZeneca, Roche, Merck & Co., Eli Lilly & Company and More

AZN

GlobeNewswire

10 days ago

Gastric Cancer Global and Regional Market Analysis 2025-2035: Focus on Treatment Type and End User with Profiles of Daiichi Sankyo, AstraZeneca, Roche, Merck & Co., Eli Lilly & Company and More

Breakthrough Properties Completes One Helix, A Cutting-edge Research Facility Fully Leased to AstraZeneca

AZN

PR Newswire

10 days ago

Breakthrough Properties Completes One Helix, A Cutting-edge Research Facility Fully Leased to AstraZeneca

AZN

Zacks Small Cap Research

10 days ago

Q&A with Mattias Bergkvist, CEO of Aixia Group | OTC Nordic Investor Day 2025

Earnings live: Spotify stock jumps on strong results, Palantir and Uber stocks fall

AZN

Yahoo Finance

10 days ago

Earnings live: Spotify stock jumps on strong results, Palantir and Uber stocks fall

AZN

MT Newswires

11 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

AZN

MT Newswires

11 days ago

Sector Update: Health Care Stocks Decline in Afternoon Trading

AZN

MT Newswires

11 days ago

Sector Update: Health Care

AZN

MT Newswires

11 days ago

AstraZeneca Shareholders Approve Harmonized Listing Structure

Phlow Corp. Congratulates the Commonwealth of Virginia and the Virginia Innovation Partnership Corporation on a Historic Investment to Create the Nation’s Largest Workforce Development Center for Advanced Pharmaceutical Manufacturing

AZN

GlobeNewswire

11 days ago

Phlow Corp. Congratulates the Commonwealth of Virginia and the Virginia Innovation Partnership Corporation on a Historic Investment to Create the Nation’s Largest Workforce Development Center for Advanced Pharmaceutical Manufacturing

AZN

MT Newswires

11 days ago

Earnings Take Centerstage as US Equity Futures Trade Mixed Pre-Bell

AZN

MT Newswires

11 days ago

Investors Digest Berkshire Hathaway Earnings as US Equity Futures Turn Mixed Pre-Bell

Earnings live: Berkshire Hathaway profits rise, Beyond Meat postpones earnings, with Palantir results on deck

AZN

Yahoo Finance

11 days ago

Earnings live: Berkshire Hathaway profits rise, Beyond Meat postpones earnings, with Palantir results on deck

AZN

Argus Research

11 days ago

Market Digest: FHI, IEX, MCO, ORLY, UTHR, VLO, META, MDLZ

Lung Cancer Antibody Drug Conjugates Research 2025: A $2 Billion Opportunity in 2030, Led by AstraZeneca, Daiichi Sankyo, Pfizer, and BMS Advancing Targeted Therapies Against HER2, TROP-2, and B7-H3

AZN

GlobeNewswire

11 days ago

Lung Cancer Antibody Drug Conjugates Research 2025: A $2 Billion Opportunity in 2030, Led by AstraZeneca, Daiichi Sankyo, Pfizer, and BMS Advancing Targeted Therapies Against HER2, TROP-2, and B7-H3

Breast Cancer Antibody Drug Conjugates Market Research 2025-2030: $7 Billion Market Led by Daiichi Sankyo and AstraZeneca, with Rising Competition from Roche, Pfizer/Seagen, ADC Therapeutics

AZN

GlobeNewswire

11 days ago

Breast Cancer Antibody Drug Conjugates Market Research 2025-2030: $7 Billion Market Led by Daiichi Sankyo and AstraZeneca, with Rising Competition from Roche, Pfizer/Seagen, ADC Therapeutics

Tariffs, pricing, backroom deals — how pharma can navigate wildly shifting policies

AZN

Pharma Voice

11 days ago

Tariffs, pricing, backroom deals — how pharma can navigate wildly shifting policies

UK's November 2025 Stocks Possibly Priced Below Estimated Value

AZN

Simply Wall St.

12 days ago

UK's November 2025 Stocks Possibly Priced Below Estimated Value

What Analysts Say Is Shaping The New Story For AstraZeneca

AZN

Simply Wall St.

12 days ago

What Analysts Say Is Shaping The New Story For AstraZeneca

SNAP benefits expire, open enrollment, earnings: What to Watch

AZN

Yahoo Finance Video

14 days ago

SNAP benefits expire, open enrollment, earnings: What to Watch

Earnings live: Amazon stock soars, Apple pares gains with earnings from AI players to come

AZN

Yahoo Finance

14 days ago

Earnings live: Amazon stock soars, Apple pares gains with earnings from AI players to come

AZN

Morningstar Research

14 days ago

Analyst Report: Ionis Pharmaceuticals, Inc.

The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot

AZN

PR Newswire

14 days ago

The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot

AstraZeneca’s gMG drug fails to fend off rivals despite Phase III win

AZN

Clinical Trials Arena

14 days ago

AstraZeneca’s gMG drug fails to fend off rivals despite Phase III win

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer

AZN

Business Wire

15 days ago

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer

AZN

MT Newswires

15 days ago

AstraZeneca Gefurulimab Shows Positive Phase 3 Results in Myasthenia Gravis Trial

Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson

AZN

GlobeNewswire

15 days ago

Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson

Competitive Landscape of Obesity Therapeutics Market Enters High-Growth Phase, Fueled by GLP-1 Surge and Expanding Oral Treatments | DataM Intelligence

AZN

PR Newswire

15 days ago

Competitive Landscape of Obesity Therapeutics Market Enters High-Growth Phase, Fueled by GLP-1 Surge and Expanding Oral Treatments | DataM Intelligence

Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal

AZN

Barrons.com

15 days ago

Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal

AZN

Investing.com

15 days ago

Merck narrows full-year sales guidance

Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal

AZN

Barrons.com

16 days ago

Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal

Nvidia worth as much as German economy as value tops $5tn

AZN

The Telegraph

16 days ago

Nvidia worth as much as German economy as value tops $5tn

UK Value Stocks Trading At Up To 49.1% Estimated Discount

AZN

Simply Wall St.

17 days ago

UK Value Stocks Trading At Up To 49.1% Estimated Discount

Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors

AZN

Zacks

17 days ago

Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

AZN

GlobeNewswire

17 days ago

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

United States Adult Vaccine Market Research and Company Analysis Report 2025-2033 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, and CSL Limited

AZN

GlobeNewswire

17 days ago

United States Adult Vaccine Market Research and Company Analysis Report 2025-2033 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, and CSL Limited

UK Market: NIOX Group And 2 Other Stocks That May Be Trading Below Estimated Value

AZN

Simply Wall St.

18 days ago

UK Market: NIOX Group And 2 Other Stocks That May Be Trading Below Estimated Value

Novavax (NVAX) Jettisons Maryland Facility to AstraZeneca as Investor Pressure Mounts—Is an Acquisition Inevitable?

AZN

Simply Wall St.

20 days ago

Novavax (NVAX) Jettisons Maryland Facility to AstraZeneca as Investor Pressure Mounts—Is an Acquisition Inevitable?

AstraZeneca (LSE:AZN): Is the Pharma Giant Undervalued After Recent Momentum?

AZN

Simply Wall St.

20 days ago

AstraZeneca (LSE:AZN): Is the Pharma Giant Undervalued After Recent Momentum?

Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue

AZN

Investor's Business Daily

21 days ago

Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue

AZN

PR Newswire

21 days ago

/C O R R E C T I O N -- Coupa Software/

A GSK Cancer Drug Is Making a Comeback. It’s So-So News for the Stock.

AZN

Barrons.com

21 days ago

A GSK Cancer Drug Is Making a Comeback. It’s So-So News for the Stock.

United States Precision Medicine Market Analysis Report 2025-2033: Developments in Biomarker Identification and Genomic Sequencing, & Combining Big Data Analytics and AI Fuel Growth

AZN

GlobeNewswire

21 days ago

United States Precision Medicine Market Analysis Report 2025-2033: Developments in Biomarker Identification and Genomic Sequencing, & Combining Big Data Analytics and AI Fuel Growth

Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue

AZN

The Wall Street Journal

21 days ago

Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue

UK Stocks That Could Be Trading Below Estimated Value In October 2025

AZN

Simply Wall St.

22 days ago

UK Stocks That Could Be Trading Below Estimated Value In October 2025

Roche in ongoing discussions with US government over drug pricing, CEO says

AZN

Pharmaceutical Technology

22 days ago

Roche in ongoing discussions with US government over drug pricing, CEO says

Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033 | Astute Analytica

AZN

GlobeNewswire

22 days ago

Radiopharmaceuticals Market to Reach US$ 13.4 Billion by 2033 | Astute Analytica

United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall

AZN

GlobeNewswire

22 days ago

United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall

Roche Raises Full-Year Earnings Outlook as U.S. Drug-Pricing Talks Continue

AZN

The Wall Street Journal

22 days ago

Roche Raises Full-Year Earnings Outlook as U.S. Drug-Pricing Talks Continue

J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN), Sets a £140 PT

AZN

Insider Monkey

23 days ago

J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN), Sets a £140 PT

AstraZeneca PLC (AZN): A Bull Case Theory

AZN

Insider Monkey

23 days ago

AstraZeneca PLC (AZN): A Bull Case Theory

Nasal Polyps Pipeline Market Research 2025: Key Players Like AstraZeneca and KeyMed Biosciences are Pivotal in Advancing Treatments, with Products Such As CM-310 and Tezepelumab Leading the Way

AZN

GlobeNewswire

23 days ago

Nasal Polyps Pipeline Market Research 2025: Key Players Like AstraZeneca and KeyMed Biosciences are Pivotal in Advancing Treatments, with Products Such As CM-310 and Tezepelumab Leading the Way

China’s Innovent Strikes Cancer Drug Deal With Takeda for Up to $11.4 Billion

AZN

The Wall Street Journal

23 days ago

China’s Innovent Strikes Cancer Drug Deal With Takeda for Up to $11.4 Billion

Thermo Scientific Revenue Rises, Boosted by Life Sciences Business

AZN

The Wall Street Journal

23 days ago

Thermo Scientific Revenue Rises, Boosted by Life Sciences Business

Fortune 500 Leaders Share AI-powered Supply Chain Excellence on Stage at OMP Conference

AZN

ACCESS Newswire

23 days ago

Fortune 500 Leaders Share AI-powered Supply Chain Excellence on Stage at OMP Conference

3 UK Stocks That May Be Trading Below Their Estimated Value

AZN

Simply Wall St.

24 days ago

3 UK Stocks That May Be Trading Below Their Estimated Value

Danaher Third-Quarter Earnings Rise; Pharma R&D Spend Expected to Rebound

AZN

The Wall Street Journal

24 days ago

Danaher Third-Quarter Earnings Rise; Pharma R&D Spend Expected to Rebound

Did IonQ Just Unlock Quantum Computing’s True Potential — And a Massive Stock Rally?

AZN

24/7 Wall St.

24 days ago

Did IonQ Just Unlock Quantum Computing’s True Potential — And a Massive Stock Rally?

CCC to Host Free LinkedIn Live Event on Responsible AI in Practice on October 30

AZN

Business Wire

24 days ago

CCC to Host Free LinkedIn Live Event on Responsible AI in Practice on October 30

Aera Technology Showcases the Enterprise Impact of Agentic Decision Intelligence at AeraHUB 25 NYC

AZN

Business Wire

24 days ago

Aera Technology Showcases the Enterprise Impact of Agentic Decision Intelligence at AeraHUB 25 NYC

AZN

Zacks

24 days ago

The Zacks Analyst Blog Highlights AstraZeneca, RTX, Applied Materials, Park Aerospace and NetSol Technologies

UK Stock Market's October 2025 Picks For Estimated Value Opportunities

AZN

Simply Wall St.

25 days ago

UK Stock Market's October 2025 Picks For Estimated Value Opportunities

Top Research Reports for AstraZeneca, RTX & Applied Materials

AZN

Zacks

25 days ago

Top Research Reports for AstraZeneca, RTX & Applied Materials

AstraZeneca's Cancer Breakthrough: Enhertu Data Sparks New Hope for Early Breast Cancer Cure

AZN

GuruFocus.com

25 days ago

AstraZeneca's Cancer Breakthrough: Enhertu Data Sparks New Hope for Early Breast Cancer Cure

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

AZN

Zacks

25 days ago

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

3 UK Stocks That May Be Undervalued In October 2025

AZN

Simply Wall St.

a month ago

3 UK Stocks That May Be Undervalued In October 2025

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option

AZN

Business Wire

a month ago

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

AZN

Business Wire

a month ago

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

How the Narrative Around AstraZeneca Is Shifting Amid New Risks and Pipeline Developments

AZN

Simply Wall St.

a month ago

Latest AstraZeneca PLC (AZN) News on November 14, 2025

Share on Social Networks: